Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Apr;99(4):810–814. doi: 10.1111/j.1476-5381.1990.tb13011.x

The actions of human atrial natriuretic factor on hepatic arterial and portal vascular beds of the anaesthetized dog.

P G Withrington 1, V G Dhume 1, R Croxton 1, A L Gerbes 1
PMCID: PMC1917535  PMID: 2141797

Abstract

1. The vascular actions of atrial natriuretic factor (ANF) have been assessed with other vasoactive agents on the hepatic arterial and portal vascular beds of the anaesthetized dog. 2. Intra-arterial bolus injections of ANF (0.1-50 nmol) caused graded increases in hepatic arterial blood flow representing a vasodilatation of relatively short duration. Vasoconstriction was never observed. 3. The maximum increase in hepatic arterial blood was the same for ANF and isoprenaline (Iso) i.e. approximately 60-70% increase over control flow. 4. On a molar basis, ANF was less potent than Iso although over the higher dose range (10(-9)-10(-7) mol) its vasodilator activity exceeded that of the endogenous vasodilator adrenaline. 5. Intraportal bolus injections (1.0-50 nmol) of ANF did not alter portal inflow resistance since no changes in portal inflow pressure occurred when the portal circuit was perfused at constant inflow volume. 6. This differential action of ANF on the hepatic arterial and portal vascular beds may provide a change in total liver blood flow in favour of the arterial component. 7. ANF, by altering hepatic haemodynamics to favour formation of trans-sinusoidal fluid exchange, may provide a temporary expansion of the extravascular fluid reservoir to buffer any increased venous pressure. However, chronically elevated plasma levels of ANF would encourage the formation of ascitic fluid.

Full text

PDF
810

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. V., Donckier J., McKenna W. J., Bloom S. R. The plasma release of atrial natriuretic peptide in man. Clin Sci (Lond) 1986 Aug;71(2):151–155. doi: 10.1042/cs0710151. [DOI] [PubMed] [Google Scholar]
  2. Bennett T. D., Rothe C. F. Hepatic capacitance responses to changes in flow and hepatic venous pressure in dogs. Am J Physiol. 1981 Jan;240(1):H18–H28. doi: 10.1152/ajpheart.1981.240.1.H18. [DOI] [PubMed] [Google Scholar]
  3. Bianchi C., Gutkowska J., Thibault G., Garcia R., Genest J., Cantin M. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 1985;82(5):441–452. doi: 10.1007/BF02450479. [DOI] [PubMed] [Google Scholar]
  4. Biollaz J., Waeber B., Nussberger J., Porchet M., Brunner-Ferber F., Otterbein E. S., Gomez H. J., Brunner H. R. Atrial natriuretic peptides: reproducibility of renal effects and response of liver blood flow. Eur J Clin Pharmacol. 1986;31(1):1–8. doi: 10.1007/BF00870977. [DOI] [PubMed] [Google Scholar]
  5. Corder R., Withrington P. G. The actions of neuropeptide Y and peptide YY on the hepatic arterial and portal vascular beds of the anaesthetized dog. Br J Pharmacol. 1988 Aug;94(4):1149–1156. doi: 10.1111/j.1476-5381.1988.tb11633.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Garcia R., Thibault G., Cantin M., Genest J. Effect of a purified atrial natriuretic factor on rat and rabbit vascular strips and vascular beds. Am J Physiol. 1984 Jul;247(1 Pt 2):R34–R39. doi: 10.1152/ajpregu.1984.247.1.R34. [DOI] [PubMed] [Google Scholar]
  7. Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of depressor neuropeptides in conscious, unrestrained, Long Evans and Brattleboro rats. Br J Pharmacol. 1988 Sep;95(1):197–208. doi: 10.1111/j.1476-5381.1988.tb16565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Genest J., Cantin M. The atrial natriuretic factor: its physiology and biochemistry. Rev Physiol Biochem Pharmacol. 1988;110:1–145. doi: 10.1007/BFb0027530. [DOI] [PubMed] [Google Scholar]
  9. Gerbes A. L., Arendt R. M., Paumgartner G. Atrial natriuretic factor. Possible implications in liver disease. J Hepatol. 1987 Aug;5(1):123–132. doi: 10.1016/s0168-8278(87)80070-3. [DOI] [PubMed] [Google Scholar]
  10. Gerbes A. L., Arendt R. M., Schnizer W., Silz S., Jüngst D., Zähringer J., Paumgartner G. Regulation of atrial natriuretic factor release in man: effect of water immersion. Klin Wochenschr. 1986 Jul 15;64(14):666–667. doi: 10.1007/BF01726920. [DOI] [PubMed] [Google Scholar]
  11. Gerbes A. L., Vollmar A. M., Xie Y., Arendt R. M. Presence of the atrial natriuretic factor (ANF) in human ascitic fluid. Life Sci. 1988;43(19):1517–1521. doi: 10.1016/0024-3205(88)90399-2. [DOI] [PubMed] [Google Scholar]
  12. Laine G. A., Hall J. T., Laine S. H., Granger J. Transsinusoidal fluid dynamics in canine liver during venous hypertension. Circ Res. 1979 Sep;45(3):317–323. doi: 10.1161/01.res.45.3.317. [DOI] [PubMed] [Google Scholar]
  13. Lautt W. W., Legare D. J., Daniels T. R. The comparative effect of administration of substances via the hepatic artery or portal vein on hepatic arterial resistance, liver blood volume and hepatic extraction in cats. Hepatology. 1984 Sep-Oct;4(5):927–932. doi: 10.1002/hep.1840040524. [DOI] [PubMed] [Google Scholar]
  14. Richardson P. D., Withrington P. G. Pressure-flow relationships and effects of noradrenaline and isoprenaline on the hepatic arterial and portal venous vascular beds of the dog. J Physiol. 1978 Sep;282:451–470. doi: 10.1113/jphysiol.1978.sp012475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Richardson P. D., Withrington P. G. The role of beta-adrenoceptors in the responses of the hepatic arterial vascular bed of the dog to phenylephrine, isoprenaline, noradrenaline and adrenaline. Br J Pharmacol. 1977 Jun;60(2):239–249. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES